Cancer Drug Beats Chemo—Stock Goes Wild

Did you see Telomir Pharma’s stock go bananas after hours? Their new cancer drug, Telomir-1, just outperformed chemo in lab tests on human cells. Imagine a future where cancer treatment is less harsh and more effective! Investors are buzzing because this isn’t just a one-off: the same drug is showing anti-aging promise in rare diseases, too. If you’re into biotech stocks or just love a good underdog story, keep an eye on this one. #Business #MakeMoney #StockMarket